A novel approach in the treatment of neuroendocrine gastrointestinal tumours. Targeting the epidermal growth factor receptor by gefitinib (ZD1839).

Source:http://linkedlifedata.com/resource/pubmed/id/14583782

Br. J. Cancer 2003 Nov 3 89 9 1766-75

Download in:

View as

Triples

General Info

PMID
14583782